These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 25751257)

  • 41. Knockdown of PLOD3 suppresses the malignant progression of renal cell carcinoma via reducing TWIST1 expression.
    Xie D; Li J; Wei S; Qi P; Ji H; Su J; Du N; Zhang X
    Mol Cell Probes; 2020 Oct; 53():101608. PubMed ID: 32585183
    [TBL] [Abstract][Full Text] [Related]  

  • 42. miR-134 functions as a tumor suppressor in cell proliferation and epithelial-to-mesenchymal Transition by targeting KRAS in renal cell carcinoma cells.
    Liu Y; Zhang M; Qian J; Bao M; Meng X; Zhang S; Zhang L; Zhao R; Li S; Cao Q; Li P; Ju X; Lu Q; Li J; Shao P; Qin C; Yin C
    DNA Cell Biol; 2015 Jun; 34(6):429-36. PubMed ID: 25811077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
    Fang Y; Wei J; Cao J; Zhao H; Liao B; Qiu S; Wang D; Luo J; Chen W
    PLoS One; 2013; 8(5):e62558. PubMed ID: 23658743
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancer of zeste homolog 2 (EZH2) promotes tumour cell migration and invasion via epigenetic repression of E-cadherin in renal cell carcinoma.
    Liu L; Xu Z; Zhong L; Wang H; Jiang S; Long Q; Xu J; Guo J
    BJU Int; 2016 Feb; 117(2):351-62. PubMed ID: 24612432
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Upregulation of centromere protein H is associated with progression of renal cell carcinoma.
    Wu X; Lin Y; Shi L; Huang Y; Lai C; Wang Y; Zhang M; Wang S; Heng B; Yu G; Du X; Fang L; Fu Y; Chen J; Guo Z; Su Z; Wu S
    J Mol Histol; 2015 Oct; 46(4-5):377-85. PubMed ID: 26248586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The epigenetic modifier CHD5 functions as a novel tumor suppressor for renal cell carcinoma and is predominantly inactivated by promoter CpG methylation.
    Du Z; Li L; Huang X; Jin J; Huang S; Zhang Q; Tao Q
    Oncotarget; 2016 Apr; 7(16):21618-30. PubMed ID: 26943038
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miRNA-205 is a candidate tumor suppressor that targets ZEB2 in renal cell carcinoma.
    Chen Z; Tang ZY; He Y; Liu LF; Li DJ; Chen X
    Oncol Res Treat; 2014; 37(11):658-64. PubMed ID: 25427583
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
    Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
    Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of SIPL1 screened by suppression subtractive hybridization (SSH) on biological function and drug resistance of renal cell carcinoma cells].
    Li CY; Yao AM; Chang XN; Guo YH; Xu R
    Zhonghua Zhong Liu Za Zhi; 2013 Dec; 35(12):897-903. PubMed ID: 24506958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.
    Zhang S; Hong Z; Chai Y; Liu Z; Du Y; Li Q; Liu Q
    Biochem Biophys Res Commun; 2017 Jun; 488(1):101-108. PubMed ID: 28479251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KDM6B induces epithelial-mesenchymal transition and enhances clear cell renal cell carcinoma metastasis through the activation of SLUG.
    Li Q; Hou L; Ding G; Li Y; Wang J; Qian B; Sun J; Wang Q
    Int J Clin Exp Pathol; 2015; 8(6):6334-44. PubMed ID: 26261509
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Melatonin inhibits MMP-9 transactivation and renal cell carcinoma metastasis by suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity.
    Lin YW; Lee LM; Lee WJ; Chu CY; Tan P; Yang YC; Chen WY; Yang SF; Hsiao M; Chien MH
    J Pineal Res; 2016 Apr; 60(3):277-90. PubMed ID: 26732239
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
    Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
    Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Highly Expressed Antisense Noncoding RNA in the INK4 Locus Promotes Growth and Invasion of Renal Clear Carcinoma Cells via the β-Catenin Pathway.
    Li Q; Tian Y; Hu G; Liang Y; Bai W; Li H
    Oncol Res; 2017 Sep; 25(8):1373-1382. PubMed ID: 28251886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.